Tuesday, April 25, 2017

UPDATE 2-Novartis sets sights on return to growth in 2018

* Advances MS drug BAF312 filing date to 2018 from 2019 (Recasts to focus on growth outlook in 2018, adds analyst comments, details)

by reutersCOMPANYNEWS via Endless Supplies .Biz - News
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)